10
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Detection of Epstein-Barr Virus in Nasal T-cell Lymphoma

, , , , , , & show all
Pages 46-49 | Published online: 08 Jul 2009

References

  • Spear GS, Walker WG Jr. Lethal midline granuloma (granuloma gangrescens) at autopsy. Bull Johns Hop-kins Hosp 1956; 99: 313–25.
  • Ho FCS, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol Oncol 1990; 8: 271–81.
  • Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/ nasopharyngeal lymphomas are peripheral T-cell neo-plasms. Am J Surg Pathol 1987; 11: 418–29.
  • Harabuchi Y, Imai S, Wakashima J, et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus. Cancer 1996; 77: 2137–49.
  • Kanavaros P, Lescs M-C, Breiere Drvine M, et al. Nasal T-cell lymphoma. A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–95.
  • Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128–30.
  • Park C-S, Manahan LJ, Brigati DJ. Automated molec-ular pathology: one hour in situ DNA hybridization. J Histotechnol 1991; 14: 219–29.
  • Reed JA, Brigati DJ, Park C-S, et al. Complete one hour immunocytochemistry based on capillary action. Bio-techniques 1992; 13: 434–41.
  • Ng CS, Chan JKC, Lo STH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987; 18: 1257–62.
  • Harabuti Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128–30.
  • Hesse J, Andersen E, Levine PH, Ebbesen P, Halberg P, Reisher JI. Antibodies to Epstein-Barr virus and cellular immunity in Hodgkin's disease and chronic lymphatic leukemia. Int J Cancer 1973; 11: 237–43.
  • Johansson B, Klein G, Henle W, Henle G. Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer 1970; 6: 450–62.
  • Levine PH, Ablashi DV, Barard CW, Carbone PP, Waggoner DE, Malan L. Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer 1971; 27: 416–21.
  • Mueller N, Evans A, Harris NL, et al. Hodgkin's disease and Epstein-Barr virus. N Engl J Med 1989; 320:689–95.
  • Pearson GR. Epstein-Barr virus and nasopharyngeal carcinoma. J Cell Biochem 1993; 17F (Suppl): 150–4.
  • Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; i: 702–4.
  • Sullivan U. Epstein-Barr virus and lymphoproliferative disease. Semin Hematol 1988; 25: 269–79.
  • Leyvraz S, Henle W, Chahinian AP, et al. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 1985; 312: 1296–9.
  • Makoshi T, Sato Y, Kameya T, Takahashi H, Shitara T. The utility of several methods for Epstein-Barr virus detection in Hodgkin's disease. Kitasato Med 1995; 25: 15–23.
  • Tao Q, Ho FCS, Loke SL, Srivastava G. Epstein-Barr virus is localized in the tumor cells of nasal lymphomas of NK, T or cell type. Int J Cancer 1995; 60: 315–20.
  • Richel DJ, Lepoutre JMM, Kapsenberg JG, et al. Epstein-Barr virus in a CD 8-positive T-cell lymphoma. Am J Pathol 1990; 36: 1093–9.
  • de Bruin PC, Jiwa M, Oudejans JJ, et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994; 83: 1612–8.
  • Sabourin J-C, Kanavaros PB, Bariere J, et al. Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in non-immunocompromised patients. Am J Surg Pathol 1993; 17: 995–1002.
  • Teramoto N, Sarker AB, Tonoyama Y, et al. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies. Cancer 1996; 77: 2339–47.
  • Park C-S, Juhng S-W, Brigati DJ, Montone KT. Anal-ysis of Epstein-Barr virus in Hodgkin's disease: experi-ence of a single university hospital in Korea. J Clin Lab Anal 1994; 8: 412–7.
  • Tao Q, Srivastava G, Chan ACL, Chung LP, Loke SL, Ho FCS. Evidence for lytic infection by Epstein-Barr virus in mucosal instead of nasopharyngeal epithelial cells in normal individuals. J Med Virol 1995; 45: 71–7.
  • Freese UK, Laux G, Hudewentz J, Schwarz E, Bornkamm GW. Two distant clusters of partially ho-mologous small repeats of Epstein-Barr virus are tran-scribed upon induction of an abortive or lytic cycle of the virus. J Virol 1983; 48: 731–43.
  • Nuebling CM, Mueller-Lantzsch N. Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeat. J Virol 1989; 63: 4609–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.